2101 COTTONTAIL LANE, SOMERSET, NJ
Market cap: $1.7B (3/18/2026)
Price: $17.87
Material disclosure
Appoints Gareth Kung to its Board of Directors
Appoints Robin Meng to its Board of Directors
Announces Preliminary Sales for CARVYKTI® for the Quarter Ended December 31, 2025
Corporate Presentation J.P. Morgan Healthcare Conference January 2026
Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Reports Third Quarter 2025 Results and Recent Highlights
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(3)
No filings found
Initial Statement of Beneficial Ownership
Submission Upload
Correspondence
Automatic Shelf Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis